We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04646005
Brief Title: Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

First Submitted : November 20, 2020
First Submitted that Met QC Criteria : November 20, 2020
First Posted : November 27, 2020

Last Update Submitted that Met QC Criteria : August 24, 2022
Last Update Posted : August 26, 2022